Stock listing

ZYME Stock Price, News, Filings & Events — Zymeworks Inc.

Selected listing: ZYME · BOATS · USD · US

This page tracks Zymeworks Inc.'s ZYME:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ZYME:BOATS. ZYME:BOATS is the stock-level entry point for investors researching Zymeworks Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Zymeworks Inc. is a public biotechnology company listed under the ticker ZYME, operating in the American market. The company focuses on developing innovative therapeutic solutions for cancer and other diseases. With a market capitalization of approximately $1.78 billion, Zymeworks is committed to advancing its proprietary technology platforms to improve patient outcomes.

ZYME:BOATSUSDUSUpdated September 11, 2026
Zymeworks Inc. logo
Ticker
ZYME:BOATS
Asset type
Stock
Market cap
$1.88B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Zymeworks Inc. ZYME:BOATS stock context

This page tracks Zymeworks Inc.'s ZYME:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ZYME:BOATS. ZYME:BOATS is the stock-level entry point for investors researching Zymeworks Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Zymeworks Inc. is a public biotechnology company listed under the ticker ZYME, operating in the American market. The company focuses on developing innovative therapeutic solutions for cancer and other diseases. With a market capitalization of approximately $1.78 billion, Zymeworks is committed to advancing its proprietary technology platforms to improve patient outcomes.

Latest news from Zymeworks Inc.

All Zymeworks Inc. news →

Zymeworks Inc. earnings calls

Research Zymeworks Inc.

Alternate listings